Tetrahydroquinoline derivatives and their use as Epac inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9751838
SERIAL NO

14432768

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to tetrahydroquinoline derivatives and their use in the treatment and/or the prevention of a disease wherein the Epac protein is involved, such as inflammation, cancer, vascular diseases, kidney diseases, cognitive disorders and cardiac diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITÉ PARIS-SACLAY3 RUE JOLIOT CURIE BÂTIMENT BREGUET GIF-SUR-YVETTE 91190

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bisserier, Malik Toulouse, FR 4 0
Blondeau, Jean-Paul Chatenay-Malabry, FR 3 0
Bouyssou, Pascal Orleans, FR 2 0
Courilleau, Delphine Chatenay-Malabry, FR 2 0
Fischmeister, Rodolphe Chatenay-Malabry, FR 4 0
Lezoualc'h, Frank Toulouse, FR 8 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00